Logos Global Management LP Iveric Bio, Inc. Transaction History

Logos Global Management LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$18.67 - $24.56 $373,400 - $491,200	20,000 Added 1.33%	1,520,000 $37 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $14.1 Million - $27.9 Million	1,500,000 New	1,500,000 $26.9 Million
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $16.4 Million - $34 Million	-1,800,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $6.08 Million - $8.42 Million	500,000 Added 38.46%	1,800,000 $30.3 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $18 Million - $24.4 Million	1,300,000 New	1,300,000 $21.7 Million

Q3 2021 Nov 15, 2021	SELL	$7.07 - $17.5 $17.7 Million - $43.8 Million	-2,500,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.69 - $7.17 $7.4 Million - $9.32 Million	1,300,000 Added 108.33%	2,500,000 $15.8 Million
Q1 2021 May 17, 2021	BUY	$5.08 - $6.89 $6.1 Million - $8.27 Million	1,200,000 New	1,200,000 $7.42 Million
Q3 2020 Nov 16, 2020	SELL	$4.01 - $6.29 $3.61 Million - $5.66 Million	-900,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $2.75 Million - $5.94 Million	900,000 New	900,000 $4.59 Million
Q1 2020 May 15, 2020	SELL	$2.83 - $8.44 $1.48 Million - $4.42 Million	-523,462 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.93 - $8.58 $486,819 - $4.49 Million	523,462 New	523,462 $4.49 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.